Moreover, CTLA-4 blockade has also been found to improve the anti-cancer effect of TILs by increasing TIL proliferation, proportion of CD8 + T cells and TIL immunoreaction, in ovarian cancer cells, compared to co-culture of IL-2 and TILs [131]. This evidence concerns the gene CTLA4 and ovarian carcinoma.